TickerFactsScreenerDevelopers

Ovid Therapeutics Inc. (OVID) — Net Income

Annual figures by fiscal year, from SEC filings.

2015: -$13.16M2016: -$22.41M2017: -$64.81M2018: -$51.98M2019: -$60.46M2020: -$81.04M2021: $122.83M2022: -$54.17M2023: -$52.34M2024: -$26.43M2025: -$17.41M-$17.41M
2015Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$17.41M+34.1%
2024-$26.43M+49.5%
2023-$52.34M+3.4%
2022-$54.17M-144.1%
2021$122.83M+251.6%
2020-$81.04M-34.0%
2019-$60.46M-16.3%
2018-$51.98M+19.8%
2017-$64.81M-189.1%
2016-$22.41M-70.3%
2015-$13.16M—